Cartesian Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $305.1M
Liabilities Breakdown FY2023
Total Liabilities: $444.7M
Asset Breakdown
Total Assets: $305.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $76.9M | 25.2% |
| Accounts Receivable | $5.9M | 1.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.1M | 0.7% |
| Goodwill | $48.2M | 15.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $172.0M | 56.4% |
Liabilities Breakdown
Total Liabilities: $444.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 0.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $441.5M | 99.3% |